Cite
HARVARD Citation
Aggarwal, P. (2019). Disproportionality analysis of bullous pemphigoid adverse events with PD-1 inhibitors in the FDA adverse event reporting system. Expert opinion on drug safety. 18 (7), pp. 623-633. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Aggarwal, P. (2019). Disproportionality analysis of bullous pemphigoid adverse events with PD-1 inhibitors in the FDA adverse event reporting system. Expert opinion on drug safety. 18 (7), pp. 623-633. [Online].